Source: Covid Medical Network

video

Presented by Ben Bornstein (Consultant and convenor of Covid Medical Network, Australia)

Anyone under the age of 45 with no medical problems has a 99.998% chance of recovery from Covid-19 without intervention with minor symptoms. Question – is there any point in vaccinating this age group? Will it stop the spread?

Dr Zelenko observes that “medical textbooks have certain criteria for ‘what’s considered a vaccine'”.

“What we’re talking about with the Moderna and the Pfizer, is experimental gene therapy that hasn’t been approved. It only has an ‘Emergency Use Authorisation’ for experimental gene therapy.”

Follow this fascinating explanation and what this means for managing the pandemic.






Related: Craig Kelly MP, Dr Vladmir Zelenko and early treatment: ‘You don’t have to fall victim to your government’s tyranny’

Dr Vladimir Zelenko and Craig Kelly MP: Who do you put your trust in?

Dr Vladimir Zelenko and Craig Kelly MP: Politics is a blood sport

Dr Vladimir Zelenko and Craig Kelly MP: Stop the fear mongering

Dr Vladimir Zelenko and Craig Kelly MP: Doing the right thing is not always the easiest thing

Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths

HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Perronne in the NEJM: ‘Recovery’ trial contested – is this finally a breach in the denial around hydroxychloroquine?

Melbourne doctors urge officials to consider hydroxychloroquine, ivermectin in fight against COVID-19

Emeritus Professor Robert Clancy responds to MP Craig Kelly’s hydroxychloroquine & ivermectin comments: Liam Bartlet‪t‬ interview

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »